Snowball logo
logo
  • Stocks
  • China
  • Healthcare
3012

Suzhou Fushilai Pharmaceutical Co. Ltd.

301258 • SHE
¥26.22¥0.00  (0%)
Estimate
P/E
64
EPS
0.41
Beta
0.38
Growth
Revenue, YoY
-20.62%
Net income, YoY
-208.03%
FCF, YoY
-160.63%
Dividends
Dividend yield
0.84%
Annual payout
¥0.22
Next ex. div date
May 29, 27
Payout
12.85%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
301258
ISIN
CNE1000058W2
Country
China
Sector (GICS)
Healthcare
Suzhou Fushilai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and internationally. The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester; L-carnosine; phosphatidylcholine products, which include glycerylphosphatidylcholine; and erelcoxib API, a nonsteroidal anti-inflammatory analgesic used to relieve the pain symptoms of osteoarthritis. Its products are used in medicines, dietary supplements, and cosmetics applications. The company also engages in research and experimental development and capital market activities. Suzhou Fushilai Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changshu, China.

Frequently asked questions

What sector does Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) operate in?

Suzhou Fushilai Pharmaceutical Co. Ltd. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) current stock price?

As of the latest data, Suzhou Fushilai Pharmaceutical Co. Ltd. stock price is CN¥26.22, with a previous close of CN¥26.22.

What is Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) current market capitalization?

Suzhou Fushilai Pharmaceutical Co. Ltd. market cap is approximately 2.40 billion.

What is Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.41.

What is Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) Price-to-Earnings (P/E) ratio?

Suzhou Fushilai Pharmaceutical Co. Ltd. current P/E ratio is 63.95.

Does Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) pay dividends?

Yes. Suzhou Fushilai Pharmaceutical Co. Ltd. pays annual dividends with an annualized yield of 0.84% and an estimated annual payout of CN¥0.22 per share.

When is the next ex-dividend date for Suzhou Fushilai Pharmaceutical Co. Ltd. (301258)?

The next ex-dividend date is scheduled for May 29, 2027.

What is Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) beta (volatility) score?

Suzhou Fushilai Pharmaceutical Co. Ltd. has a beta of 0.380, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.